Toxicity Assessment

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

More Than 200 Abstracts At ASH And SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current ...

Published December 5, 2008, 3:16 am, Medical News Today

More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing collaboration with the oncology community.

Discover News | Full Story


More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current ...

Published December 3, 2008, 10:25 pm, PR Newswire via Yahoo! Finance

Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH

Discover News | Full Story


HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) ...

Published December 3, 2008, 5:30 am, PR Newswire via Yahoo! Finance

HemoGenix® and ORF Genetics announce the collaboration and implementation of biorisk-free, green-source growth factors and cytokines for use in all HALO® Assay Kits and HALO® Contract Research Services where the response of human blood-forming cells is detected.

Discover News | Full Story


FDA doesn't mind superfluous toxins

Published December 3, 2008, 5:08 am, The Daily Iowan

The Food and Drug Administration issued a conclusion on Nov. 28 concerning the safety and relative toxicity of melamine in baby formula, claiming that 1 part per million can cause no real harm. This study is a response to the September outcry over China's use of the substance in dairy products, which caused thousands of infants to fall sick and at least four to die, in addition to the cats and ...

Discover News | Full Story


Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey

Published December 3, 2008, 3:30 am, PR Newswire via Yahoo! Finance

Vical Incorporated today announced an exclusive, binding letter of intent with EIP Eczacibasi Ilac Pazarlama A.S. for sales and marketing of the company's Allovectin-7® immunotherapeutic product candidate in Turkey and the Turkish Republic of Northern Cyprus.

Discover News | Full Story


Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

Published December 3, 2008, 3:11 am, Medical News Today

Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT-501, met all primary endpoints.

Discover News | Full Story


Horizon Therapeutics announces HZT-501 trials meet primary endpoints

Published December 3, 2008, 2:06 am, News-Medical-Net

Horizon Therapeutics, Inc. has announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints.

Discover News | Full Story


Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints

Published December 2, 2008, 8:27 am, EurekAlert!

( WeissComm Partners ) Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints. HZT 501, a novel, proprietary fixed-dose combination product containing ibuprofen and famotidine, demonstrated a statistically significant reduction in the ...

Discover News | Full Story


Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

Published December 2, 2008, 5:30 am, PR Newswire via Yahoo! Finance

Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT-501, met all primary endpoints.

Discover News | Full Story


Study Demonstrates The Benefit Of Using Chemoradiotherapy In Elderly Patients With Locally Advanced Oesophageal Cancer

Published December 2, 2008, 4:12 am, Medical News Today

Chemoradiotherapy (CRT) can be considered an "effective" treatment for elderly patients with locally advanced oesophageal cancer, reports the British Journal of Cancer.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a